Axis(TM) Solvent-dehydrate Dermal Allograft in the Treatment of Pelvic Organ Prolapse.
Condition(s):Pelvic Organ ProlapseLast Updated:February 16, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Pelvic Organ ProlapseLast Updated:February 16, 2024Active, not recruiting
Condition(s):Pelvic Organ ProlapseLast Updated:May 5, 2022Recruiting
Condition(s):Pelvic Organ ProlapseLast Updated:December 16, 2015Unknown status
Condition(s):Pelvic Organ ProlapseLast Updated:December 19, 2023Recruiting
Condition(s):Pelvic Organ ProlapseLast Updated:February 1, 2023Completed
Condition(s):Urogenital ProlapseLast Updated:August 6, 2021Completed
Condition(s):Nocturia; Pelvic Organ ProlapseLast Updated:June 2, 2016Withdrawn
Condition(s):Pelvic Organ ProlapseLast Updated:November 7, 2023Recruiting
Condition(s):Pelvic Organ ProlapseLast Updated:May 9, 2014Completed
Condition(s):Pelvic Organ ProlapseLast Updated:April 25, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.